Endothelin receptors as a potential therapeutic target in the treatment of cardiovascular disease: Rationale for selective antagonism of the ET(A) subtype

被引：0
|
作者：
Webb, ML
Liu, ECK
Aversa, CR
Spinale, FG
Russell, ME
机构：
[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT CARDIOVASC BIOCHEM,PRINCETON,NJ 08543
[2] MED UNIV S CAROLINA,DIV CARDIOTHORAC SURG,CHARLESTON,SC 29425
[3] HARVARD UNIV,BRIGHAM & WOMENS HOSP,DEPT MED,SCH MED,BOSTON,MA 02115
来源：
DRUG NEWS & PERSPECTIVES | 1996年 / 9卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：348 / 350
页数：3
相关论文
共 50 条
  • [31] Serotonin Receptors as a Potential Target in the Treatment of Alzheimer's Disease
    Eremin, Dmitrii V.
    Kondaurova, Elena M.
    Rodnyy, Aleksander Ya.
    Molobekova, Camilla A.
    Kudlay, Dmitrii A.
    Naumenko, Vladimir S.
    BIOCHEMISTRY-MOSCOW, 2023, 88 (12-13) : 2023 - 2042
  • [32] Liver X receptors conserve the therapeutic target potential for the treatment of rheumatoid arthritis
    Mai, Chu-Tian
    Zheng, De-Chong
    Li, Xin-Zhi
    Zhou, Hua
    Xie, Ying
    PHARMACOLOGICAL RESEARCH, 2021, 170
  • [33] GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease-A Systematic Review
    Mori, Yusaku
    Matsui, Takanori
    Hirano, Tsutomu
    Yamagishi, Sho-ichi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
  • [34] New insight and therapeutic strategies in cardiovascular disease and focus on endothelial target: Endothelin-1 and angina
    Lerman, A
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 : S27 - S30
  • [35] More purinergic receptors deserve attention as therapeutic targets for the treatment of cardiovascular disease
    Wernly, Bernhard
    Zhou, Zhichao
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2020, 319 (04): : H723 - H729
  • [36] Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
    Pernow, John
    Jung, Christian
    CARDIOVASCULAR RESEARCH, 2013, 98 (03) : 334 - 343
  • [37] 2-arachidonoylglycerol might be a novel therapeutic target in the treatment of cardiovascular disease
    Liu, Jingwen
    Li, Tai
    Wang, Hongkun
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 332 : 162 - 162
  • [38] The potential of FimH as a novel therapeutic target for the treatment of Crohn's disease
    Sivignon, Adeline
    Bouckaert, Julie
    Bernard, Julien
    Gouin, Sebastien G.
    Barnich, Nicolas
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (09) : 837 - 847
  • [39] The cardiac gap junction: A potential therapeutic target in the treatment of heart disease
    Liu, FY
    Gutstein, DE
    MOUNT SINAI JOURNAL OF MEDICINE, 2002, 69 (06): : 421 - 424
  • [40] P2X Receptors in the Cardiovascular System and their Potential as Therapeutic Targets in Disease
    Ralevic, Vera
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (07) : 851 - 865
12345